4 results  1 of 1 

1 Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience
Ah Ran Cho, Young Hee Yoon, June-Gone Kim, Yoon Jeon Kim, Joo Yong Lee
J Korean Med Sci.2018;33(7):e55.  Published online 2018 January 10     DOI: http://dx.doi.org/10.3346/jkms.2018.33.e55
      
2 A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma
Sung Han Kim, Seong Il Seo, Hyun Moo Lee, Han-Yong Choi, Seung Hyun Jeon, Hyung-Lae Lee, Tae Gyun Kwon, Yong-June Kim, Wun-Jae Kim, Jinsoo Chung
J Korean Med Sci.2016;31(12):1983-1988.   Published online 2016 September 20     DOI: http://dx.doi.org/10.3346/jkms.2016.31.12.1983
      
3 Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute
Younak Choi, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
Cancer Res Treat.2015;47(4):555-563.   Published online 2015 February 16     DOI: http://dx.doi.org/10.4143/crt.2014.200
      
4 A Perspective: Role of Targeted Therapy in Colon Cancer
Hyun Hee Chung, Byung Ik Jang
Korean J Gastroenterol.2013;61(3):128-135.   Published online 2013 March 21     DOI: http://dx.doi.org/10.4166/kjg.2013.61.3.128
      

 1 of 1